As the Trump White House this week announced a major deal to pivot photo giant Kodak toward pharmaceutical manufacturing, it made clear this was just the first step in a broader plan to break Chinese dominance of supply chain in manufacturing. With a focus first on healthcare manufacturing, the White House brokered a $765 million loan to Kodak after noticing 90% of the main ingredients of the most common pharmaceuticals taken each day in the United States are manufactured abroad. Adam Boehler, CEO of U.S. International Development Finance Corporation, is a lead administration official on the Kodak deal, and said...